Pain News and Research

Latest Pain News and Research

Compassion fatigue: Impact on healthcare providers of caring for the terminally ill

Compassion fatigue in nurses, doctors and other front line cancer-care providers significantly impacts how they interact with patients, with patient families, with other healthcare workers, and with their own family, according to analysis by Indiana University School of Medicine and Regenstrief Institute researchers published in the March issue of the Journal of Health Psychology.

1 Apr 2009

CeNeRx BioPharma awarded patent for novel compounds that selectively target peripheral cannabinoid receptors

CeNeRx BioPharma, Inc. has announced issuance of a new U.S. patent covering its novel compounds that selectively target peripheral cannabinoid receptors.

1 Apr 2009

Branding still overshadows critical fine print on nonprescription medications

Medicine packages barrage consumers with information, some required to be "prominent" and "conspicuous."

1 Apr 2009

How to resist temptation

Here's good news for dieters who face food challenges in the break room every day: A new study in the Journal of Consumer Research shows that our resistance gets a boost after we've just been exposed to similar temptations.

1 Apr 2009

Hospital-to-hospital health information exchange begins

LifeBridge Health has begun an electronic exchange of health information between its two hospitals, Sinai Hospital of Baltimore and Northwest Hospital, and Saint Agnes Hospital, a community hospital with an overlapping service area.

1 Apr 2009

Heart burn surgery reverses chronic rejection in transplant patient

Acid reflux is thought to be - at most - an irritating condition easily controlled with medication, diet and weight loss.

1 Apr 2009

District Court decision received in Concerta patent sase

The U.S. District Court for the District of Delaware has rendered a decision in the patent litigation between Alza Corporation, McNeil-PPC, Inc. and Andrx Pharmaceuticals LLC. McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., which markets Concerta (methylphenidate HCI) Extended-Release Tablets CII, said the court held that the patent in suit is not valid or infringed by the filing of Andrx's Abbreviated New Drug Application.

1 Apr 2009

University of Nottingham back pain study wins prestigious research prize

A study aimed at overcoming problems with treatments for a common cause of back pain has picked up one of the most prestigious prizes in spinal research.

31 Mar 2009

Ultrasound saves money, improves rheumatologic care

A few years back, 76-year-old Joseph Buggie woke up to pain so throbbing, he couldn't muster the strength to roll over, let alone crawl out of bed.

31 Mar 2009

World Heart Federation, Daiichi Sankyo and Lilly Partner to improve cardiovascular health

The World Heart Federation, Daiichi Sankyo Company, and Eli Lilly announced today that they have partnered to improve cardiovascular health internationally. The organizations made the announcement at the 58th Annual Scientific Session of the American College of Cardiology in Orlando, Florida.

31 Mar 2009

Study answers question of timing in use of eptifibatide

An international study to resolve a decade of debate over the best timing for administering an anti-clotting drug for certain heart patients has come up with an answer: It doesn't matter.

30 Mar 2009

New York Times examines challenges faced by a Minneapolis hospital that treats many Somali, Hispanic patients

The New York Times on Sunday profiled the Hennepin County Medical Center, a Minneapolis-based hospital that "offers an extraordinary vantage point on the ways immigrants are testing the American medical establishment."

30 Mar 2009

FDA approves IXIARO for Japanese encephalitis

The U.S. Food and Drug Administration has approved IXIARO, a vaccine to prevent Japanese encephalitis (JE) which is caused by a mosquito-transmitted virus found mainly in Asia. IXIARO will be the only vaccine for JE available in the United States.

30 Mar 2009

New tool in the radiography approach will assist in earlier detection of asbestos-related diseases

Michael Harbut, M.D., MPH, co-director of the National Center for Vermiculite and Asbestos-Related Cancers (NCVAC) at the Barbara Ann Karmanos Cancer Institute in Detroit, MI, and chief of the Center for Occupational and Environmental Medicine Wayne State University, announced the use of a new technology to aid in the diagnosis of asbestos-related lung disease.

30 Mar 2009

NTRILIPIX (fenofibric acid) in combo with Rosuvastatin calcium shows improvement on key lipids for cholesterol management

Data from a new study showed that Abbott's TRILIPIX (fenofibric acid) delayed-release capsules in combination with rosuvastatin calcium met all of the study's primary endpoints.

29 Mar 2009